Home > Before & After > Clinical Trial Gallery
Before & After — Our Clinical Trial Gallery A revealing look at everyday people with real results
We conducted a clinical trial of participants using LATISSE® (bimatoprost ophthalmic solution) 0.03%, and documented their progress throughout the 16-week treatment period. The results were more than eye-catching: 78% of participants (18% for vehicle) experienced a significant increase in overall eyelash prominence (including elements of length, fullness, and darkness) at week 16. The following case studies capture these images. These are real women with real results. Their lashes have not been retouched.

Explore the Gallery.

Select a case study on the left and press play to view the slideshow, or slide the time-lapse bar to see the lash growth per week.
PRINT PAGE
SHARE THIS
READ MORE
Individual results may vary. The lashes displayed have not been retouched.
If you stop using LATISSE®, your eyelashes are expected to return to their previous appearance over several weeks to months.

Vehicle is the same solution as LATISSE®, without the active ingredient.
LATISSE® solution is a prescription treatment for hypotrichosis used to grow eyelashes, making them longer, thicker and darker.
Eyelash hypotrichosis is another name for having inadequate or not enough eyelashes.
Important Safety Information
If you are using prescription products for lowering eye pressure or have a history of eye pressure problems, only use LATISSE® under close doctor supervision. May cause eyelid skin darkening which may be reversible, and there is potential for increased brown iris pigmentation which is likely to be permanent. There is a potential for hair growth to occur in areas where LATISSE® solution comes in repeated contact with skin surfaces. If you develop or experience any eye problems or have eye surgery, consult your doctor immediately about continued use of LATISSE®. The most common side effects after using LATISSE® solution are an itching sensation in the eyes and/or eye redness.
Please see Full Prescribing Information link below.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
ALLERGAN © 2009 Allergan, Inc. Irvine, CA 92612. ® mark owned by Allergan, Inc.

© 2009 Make-A-Wish Foundation of America. Make-A-Wish Foundation and the
Make-A-Wish logo are registered trademarks of the Make-A-Wish Foundation of America.

APC69GH09